GlassScriptPhysician profile
Diamond Robinson
NPI 1447870894
$7,418.38
in general payments reported to CMS, 2019-2025
20 companies · $1,525 in 2025
The $1,525 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $53.25 · 2022: $1,637 · 2023: $1,958 · 2024: $2,245 · 2025: $1,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,728.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,017.01 | 2022-2025 | |
| Amgen INC. | $1,173.84 | 2021-2025 | Enbrel, Otezla, Tavneos |
| Ucb, INC. | $799.16 | 2022-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $538.10 | 2022-2025 | Tremfya, Simponi Aria |
| Glaxosmithkline, LLC. | $321.29 | 2023-2025 | Benlysta |
| Lilly USA, LLC | $290.21 | 2022-2024 | Taltz |
| Novartis Pharmaceuticals Corporation | $264.51 | 2023-2025 | |
| Mallinckrodt Hospital Products INC. | $191.53 | 2022-2025 | Acthar |
| Astrazeneca Pharmaceuticals LP | $177.30 | 2022-2025 | Saphnelo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.42 | 2021-2025 | Ofev, Cyltezo |
| Organon LLC | $90.89 | 2023-2025 | Hadlima, Renflexis |
| Fresenius Kabi USA, LLC | $88.85 | 2023-2024 | Idacio |
| Aurinia Pharma U.S., INC. | $72.95 | 2024-2025 | Lupkynis |
| Sobi, INC | $65.83 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $63.07 | 2022-2024 | Strensiq |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $28.56 | 2023 | Actemra |
| Almatica Pharma LLC | $25.28 | 2025 | Teriparatide |
| Ani Pharmaceuticals, INC. | $20.57 | 2022 | |
| Radius Health, INC. | $17.55 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.46 | 2024 | Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diamond Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.